The Series D funds will support the company’s FDA premarket approval and US launch for its liquid nitrogen spray cryotherapy ...

Cryotherapy market Size, Share. PORTLAND, OR, UNITED STATES, September 10, 2024 /EINPresswire / -- The global cryotherapy market , valued at $213 million i ...

SMTI, along with InfuSystem, inked a U.S. distribution agreement with ChemoMouthpiece. Under the agreement, ChemoMouthpiece's oral cryotherapy device will be distributed in cancer centers.

InfuSystem Holdings, Inc. ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care ...

We believe this exclusive agreement, which builds on our partnership, will allow us to do that by offering the Chemo Mouthpiece®, an oral cryotherapy device, bringing potential relief to ...

InfuSystem and Sanara MedTech Inc. have executed an exclusive U.S. distribution agreement with ChemoMouthpiece, a device for the treatment of oral mucositis in chemotherapy patients.